+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria



Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria



Journal of Clinical Microbiology 34(10): 2640-2641



To assess the impact of the antiseptic effects of silver sulfadiazine-chlorhexidine-impregnated central venous catheters on catheter culture systems, a series of in vitro experiments was performed. Segments of antiseptic- and non-antiseptic-impregnated catheters were sonicated in thioglycolate broth and removed. After the addition of 10-3 CFU of Staphylococcus epidermidis per ml, aliquots of catheter-exposed broth were subcultured onto blood agar at 15-min intervals. Decreased mean colony counts were noted at 45 min for broth exposed to antiseptic-impregnated catheters compared with the colony counts for broth exposed to non-antiseptic-impregnated catheters (170 versus 540 CFU/ml). These effects, which were also demonstrated by the roll-plate method, were abrogated by the use of medium containing inhibitors of silver sulfadiazine and chlorhexidine. To assess the duration of the antiseptic effects, catheter segments were suspended for up to 14 days in phosphate-buffered saline, incubated with 10-6 CFU of S. epidermidis per ml, and cultured. Inhibition of bacterial growth by antiseptic-impregnated catheters disappeared after 14 days. These studies suggest that antiseptic compounds elute from catheters during broth- and solid medium-based culturing processes, making necessary the addition of inhibitors of these compounds in culture media. They further suggest that the antimicrobial effects of antiseptic-impregnated catheters wane within several days of placement.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008825723

Download citation: RISBibTeXText

PMID: 8880544


Related references

Chlorhexidine-silver sulfadiazine-impregnated central venous catheters: in vitro antibacterial activity and impact on bacterial adhesion. New Microbiologica 35(2): 175-182, 2012

The impact of antiseptic-impregnated central venous catheters on the in-vitro quantitation of catheter-associated bacteria by standard catheter culture methods. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 33: 273, 1993

Impact of minocycline/rifampin-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria. Abstracts of the General Meeting of the American Society for Microbiology 100: 195-196, 2000

Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study. Journal of Hospital Infection 72(3): 227-233, 2009

Effectiveness of Minocycline/Rifampin vs Chlorhexidine/Silver Sulfadiazine-Impregnated Central Venous Catheters. Journal of the American College of Surgeons 221(4): 891-892, 2015

Anaphylactic shock associated with a central venous catheter impregnated with chlorhexidine and silver sulfadiazine. Masui. Japanese Journal of Anesthesiology 47(5): 556-561, 1998

Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly. American Journal of Infection Control 44(1): 50-53, 2016

Inhibitory effect of explanted chlorhexidine-silver sulfadiazine impregnated central venous catheters on Staphylococcus epidermidis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 422, 2000

Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Annals of Internal Medicine 143(8): 570-580, 2005

Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter. Annals of Hematology 84(4): 258-262, 2005

Reduction of central venous catheter-related infection in cancer patients with severe neutropenia A prospective controlled randomized trial using a chlorhexidine and silver-sulfadiazine impregnated central venous line. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 447, 2001

Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. Journal of Hospital Infection 37(2): 145-156, 1997

Susceptibility of coagulase-negative staphylococcal nosocomial bloodstream isolates to the chlorhexidine/silver sulfadiazine-impregnated central venous catheter. American Journal of Infection Control 32(8): 486-488, 2004

The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation. European Journal of Cancer Care 18(5): 477-482, 2009

Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs. American Journal of Infection Control 42(3): 321-324, 2014